BiochemistrybioRxivPreprint
The BCKDK inhibitor BT2 is a chemical uncoupler that lowers mitochondrial ROS production and de novo lipogenesis
A. Acevedo, A. E. Jones, B. T. Danna…·A. S. Divakaruni
The paper shows BT2 acts as a mitochondrial uncoupler, reducing ROS and lipogenesis, which may explain its therapeutic benefits in metabolic diseases.
DOI 10.1101/2023.08.15.553413